Exos TFP Holdings’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Exos TFP Holdings’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-276,688	Closed	-$2.84M	–	263
2023 Q2	$2.84M	Sell	276,688 -96,036	-26%	-$980K	1.4%	25
2023 Q1	$3.77M	Buy	372,724 +194,995	+110%	+$1.96M	0.95%	21
2022 Q4	$1.78M	Buy	177,729 +102,025	+135%	+$1M	0.49%	70
2022 Q3	$737K	Buy	+75,704	New	+$736K	0.34%	90

Exos TFP Holdings's DALS Position: Q3 2023 in Review

Exos TFP Holdings sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 276,688 shares — an estimated $2.84M sold.

Exos TFP Holdings first reported a position in DALS in Q3 2022 and held it in 4 quarters. The position peaked at $3.77M in Q1 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

Exos TFP Holdings reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Exos TFP Holdings sold 276,688 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $2.84M.
Exos TFP Holdings first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 4 quarters.
Exos TFP Holdings's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $3.77M in Q1 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on Exos TFP Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.